Workflow
送转填权
icon
Search documents
宁德时代跌2.00%,成交额25.52亿元,主力资金净流出2.04亿元
Xin Lang Cai Jing· 2025-10-22 02:06
Core Viewpoint - CATL's stock price has shown a significant increase of 42.10% year-to-date, despite a recent decline of 2.00% on October 22, 2023, indicating volatility in the market [2][1]. Company Overview - CATL, established on December 16, 2011, and listed on June 11, 2018, is primarily engaged in the research, production, and sales of power batteries and energy storage batteries, with applications in various sectors including passenger vehicles, commercial vehicles, and energy storage [2]. - The company's revenue composition includes 73.55% from power battery systems, 15.88% from energy storage systems, 4.41% from battery materials and recycling, 4.28% from other sources, and 1.88% from battery mineral resources [2]. Financial Performance - For the period from January to September 2025, CATL reported a revenue of 283.07 billion yuan, reflecting a year-on-year growth of 9.28%, while the net profit attributable to shareholders increased by 36.20% to 49.03 billion yuan [3]. - Cumulatively, CATL has distributed 61.11 billion yuan in dividends since its A-share listing, with 58.16 billion yuan distributed over the past three years [4]. Shareholder Information - As of September 30, 2025, CATL had 227,500 shareholders, with an average of 18,712 circulating shares per person, a slight decrease of 0.40% from the previous period [3]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 661 million shares, which increased by 53.92 million shares compared to the previous period [4].
华阳股份跌2.10%,成交额9387.07万元,主力资金净流出347.72万元
Xin Lang Cai Jing· 2025-10-22 02:06
Core Viewpoint - Huayang Co., Ltd. has experienced a decline in stock price and a mixed performance in trading volume, while its financial results show a decrease in revenue and net profit for the first half of 2025 [1][2]. Financial Performance - As of October 20, 2025, Huayang Co., Ltd. reported a revenue of 11.24 billion yuan, a year-on-year decrease of 7.86%, and a net profit attributable to shareholders of 783 million yuan, down 39.75% year-on-year [2]. - The company has cumulatively distributed 12.93 billion yuan in dividends since its A-share listing, with 5.81 billion yuan distributed in the last three years [3]. Stock Market Activity - On October 22, 2025, Huayang Co., Ltd.'s stock price fell by 2.10% to 7.94 yuan per share, with a trading volume of 93.87 million yuan and a turnover rate of 0.33%, resulting in a total market capitalization of 28.644 billion yuan [1]. - The stock has increased by 17.09% year-to-date, with a 4.34% rise over the last five trading days and a 10.74% increase over the last 20 days [1]. Shareholder Structure - As of June 30, 2025, the number of Huayang Co., Ltd. shareholders increased to 97,000, with an average of 37,190 circulating shares per person, a decrease of 7.22% from the previous period [2][3]. - Major shareholders include Hong Kong Central Clearing Limited and various ETFs, with notable increases in holdings for several funds [3]. Business Overview - Huayang Co., Ltd. is primarily engaged in coal production, processing, and sales, as well as electricity and heat production, solar power generation, and related technologies [2]. - The company's revenue composition includes 52.34% from raw coal, 13.21% from other sources, and smaller percentages from various coal products and electricity sales [2].
利扬芯片涨2.05%,成交额1.37亿元,主力资金净流入143.32万元
Xin Lang Cai Jing· 2025-10-16 03:38
Group 1: Company Overview - Liyang Chip Testing Co., Ltd. is located in Dongguan, Guangdong Province, established on February 10, 2010, and listed on November 11, 2020 [2] - The company's main business includes integrated circuit testing solution development, wafer testing services, chip finished product testing services, and related supporting services [2] - The revenue composition of the main business is as follows: finished chip testing 58.15%, wafer testing 35.08%, other (supplementary) 4.39%, and wafer dicing 2.37% [2] Group 2: Financial Performance - For the period from January to June 2025, Liyang Chip achieved operating revenue of 284 million yuan, a year-on-year increase of 23.09%, and a net profit attributable to the parent company of -7.06 million yuan, a year-on-year increase of 16.38% [2] - The company has cumulatively distributed cash dividends of 120 million yuan since its A-share listing, with a total of 2.003 million yuan distributed over the past three years [3] Group 3: Stock Performance - As of October 16, Liyang Chip's stock price increased by 2.05% to 32.38 yuan per share, with a total market capitalization of 6.583 billion yuan [1] - The stock has risen 61.34% year-to-date, with a recent decline of 6.09% over the past five trading days, and a 25.75% increase over the past 20 days [1] - The company has appeared on the "Dragon and Tiger List" four times this year, with the most recent appearance on September 17, where it recorded a net purchase of 10.6543 million yuan [1]
运达股份涨2.00%,成交额1.41亿元,主力资金净流出253.90万元
Xin Lang Cai Jing· 2025-09-29 02:08
Core Insights - Yunda Co., Ltd. has seen a stock price increase of 50.68% year-to-date, with a recent 9.66% rise over the last five trading days and a 26.02% increase over the past 20 days [2] - The company specializes in the research, production, and sales of large wind turbine generators, with 87.54% of its revenue coming from wind turbine sales [2] Financial Performance - For the first half of 2025, Yunda Co., Ltd. reported a revenue of 10.894 billion yuan, reflecting a year-on-year growth of 26.27%, while the net profit attributable to shareholders was 144 million yuan, a decrease of 2.62% compared to the previous year [2] - Cumulative cash dividends since the company's A-share listing amount to 281 million yuan, with 153 million yuan distributed over the last three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 12.53% to 38,400, while the average circulating shares per person decreased by 10.80% to 18,153 shares [2] - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 10.8234 million shares, a decrease of 5.5642 million shares from the previous period [3]
运达股份涨2.12%,成交额2.41亿元,主力资金净流出1200.65万元
Xin Lang Cai Jing· 2025-09-24 05:50
Core Viewpoint - Yunda Co., Ltd. has shown a significant increase in stock price this year, with a 39% rise, despite a recent decline in the last five trading days [1][2]. Company Overview - Yunda Energy Technology Group Co., Ltd. is located in Hangzhou, Zhejiang Province, and was established on November 30, 2001, with its listing date on April 26, 2019 [1]. - The company specializes in the research, production, and sales of large wind turbine generators, with its main business revenue composition being: wind turbine generators 87.54%, new energy EPC contracting 6.36%, others 4.04%, and power generation income 2.06% [1]. Financial Performance - For the first half of 2025, Yunda Co., Ltd. achieved an operating income of 10.894 billion yuan, representing a year-on-year growth of 26.27%, while the net profit attributable to shareholders decreased by 2.62% to 144 million yuan [2]. - The company has distributed a total of 281 million yuan in dividends since its A-share listing, with 153 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Yunda Co., Ltd. increased by 12.53% to 38,400, while the average circulating shares per person decreased by 10.80% to 18,153 shares [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 10.8234 million shares, a decrease of 5.5642 million shares from the previous period [3].
泰恩康跌2.03%,成交额1.14亿元,主力资金净流出1306.31万元
Xin Lang Zheng Quan· 2025-09-23 03:19
Group 1 - The core viewpoint of the news is that 泰恩康's stock has experienced a significant decline recently despite a substantial increase in its price year-to-date, indicating potential volatility in the market [1][2]. - As of September 23, 泰恩康's stock price was 33.84 yuan per share, with a market capitalization of 14.399 billion yuan [1]. - The company has seen a year-to-date stock price increase of 128.79%, but it has declined by 12.42% over the last five trading days [1]. Group 2 - 泰恩康's main business segments include pharmaceutical agency (65.16%), pharmaceutical manufacturing (31.70%), and pharmaceutical technology services (2.97%) [1]. - As of June 30, the number of shareholders decreased by 33.05% to 10,900, while the average circulating shares per person increased by 49.36% to 27,747 shares [2]. - For the first half of 2025, 泰恩康 reported a revenue of 347 million yuan, a year-on-year decrease of 12.23%, and a net profit of 37.084 million yuan, down 56.75% year-on-year [2]. Group 3 - Since its A-share listing, 泰恩康 has distributed a total of 460 million yuan in dividends, with 377 million yuan distributed over the past three years [3].
健之佳跌2.05%,成交额1205.59万元,主力资金净流出62.31万元
Xin Lang Cai Jing· 2025-09-23 02:17
Core Viewpoint - The stock price of Jianzhijia has experienced a decline of 6.47% year-to-date, with significant drops in recent trading days, indicating potential challenges in the company's market performance [2]. Company Overview - Jianzhijia Pharmaceutical Chain Group Co., Ltd. is located in Kunming, Yunnan Province, established on September 27, 2004, and listed on December 1, 2020. The company specializes in the retail of health products, including pharmaceuticals, health foods, personal care items, and daily consumables [2]. - The revenue composition of Jianzhijia includes: prescription and non-prescription drugs (72.60%), with non-prescription drugs at 39.64% and prescription drugs at 32.96%. Other segments include medical devices (7.44%), convenience products (5.05%), health foods (4.84%), and personal care products (1.18%) [2]. Financial Performance - For the first half of 2025, Jianzhijia reported a revenue of 4.457 billion yuan, a year-on-year decrease of 0.64%. However, the net profit attributable to shareholders increased by 15.11% to 72.3782 million yuan [2]. - Since its A-share listing, Jianzhijia has distributed a total of 715 million yuan in dividends, with 473 million yuan distributed over the past three years [3]. Shareholder and Institutional Holdings - As of June 30, 2025, Jianzhijia had 15,100 shareholders, a decrease of 12.99% from the previous period. The average number of circulating shares per shareholder increased by 26.21% to 10,236 shares [2]. - Among the top ten circulating shareholders, Rongtong Health Industry Flexible Allocation Mixed A/B holds 7.1 million shares, a decrease of 294,800 shares from the previous period. Meanwhile, Guangfa Innovation Upgrade Mixed has entered the list as a new shareholder with 1.7029 million shares [4].
宏辉果蔬跌2.02%,成交额1.11亿元,主力资金净流出451.22万元
Xin Lang Cai Jing· 2025-09-22 05:35
Core Viewpoint - The stock of Honghui Fruits and Vegetables has experienced a significant increase of 127.63% year-to-date, but has recently seen a decline of 3.38% over the past five trading days, indicating volatility in its performance [2]. Company Overview - Honghui Fruits and Vegetables Co., Ltd. was established on December 10, 1992, and listed on November 24, 2016. The company is located in Longhu District, Shantou City, Guangdong Province [2]. - The main business involves the management of fruit and vegetable products, including planting, post-harvest acquisition, pre-cooling, frozen storage, sorting, processing, packaging, and cold chain distribution. Key products include various high-quality fruits and vegetables from both domestic and imported sources [2]. - The revenue composition of the company is as follows: fruits 76.18%, frozen meat 16.50%, frozen foods 2.98%, vegetables 2.33%, cooking oil 1.60%, and others 0.41% [2]. Financial Performance - As of June 30, the number of shareholders for Honghui Fruits and Vegetables was 30,600, a decrease of 10.66% from the previous period. The average circulating shares per person increased by 11.93% to 18,647 shares [3]. - For the first half of 2025, the company achieved a revenue of 470 million yuan, representing a year-on-year growth of 7.86%. However, the net profit attributable to shareholders decreased by 44.82% to 6.92 million yuan [3]. Market Activity - On September 22, the stock price of Honghui Fruits and Vegetables fell by 2.02%, trading at 9.72 yuan per share with a total transaction volume of 111 million yuan and a turnover rate of 1.86%. The total market capitalization is 5.917 billion yuan [1]. - In terms of capital flow, there was a net outflow of 4.5122 million yuan from major funds, with large orders accounting for 19.51% of purchases and 22.96% of sales [1]. Dividend Information - Since its A-share listing, Honghui Fruits and Vegetables has distributed a total of 136 million yuan in dividends, with 15.3556 million yuan distributed over the past three years [4].
家联科技跌3.16%,成交额8314.84万元,近5日主力净流入-981.71万
Xin Lang Cai Jing· 2025-09-18 07:31
Core Viewpoint - The company, Ningbo Jialian Technology Co., Ltd., specializes in the research, production, and sales of plastic products, biodegradable products, and plant fiber products, with a significant focus on overseas markets and emerging technologies like 3D printing [2][7]. Group 1: Company Overview - Ningbo Jialian Technology was established on August 7, 2009, and went public on December 9, 2021. The company is located in Zhenhai District, Ningbo, Zhejiang Province [7]. - The main business revenue composition includes plastic products (84.41%), biodegradable products (14.25%), and other products (1.34%) [7]. - The company is recognized as a leading manufacturer in the global plastic dining utensils industry, with a significant portion of sales directed towards overseas markets, particularly in North America, Europe, and Oceania [2][3]. Group 2: Financial Performance - For the first half of 2025, the company achieved a revenue of 1.123 billion yuan, reflecting a year-on-year growth of 5.26%. However, the net profit attributable to the parent company was a loss of 64.67 million yuan, a decrease of 204.81% compared to the previous year [8]. - As of June 30, the number of shareholders increased by 3.72% to 5,906, with an average of 22,811 circulating shares per person, up by 34.95% [8]. Group 3: Market Dynamics - The company benefits from the depreciation of the RMB, with overseas revenue accounting for 55.43% of total revenue as of the 2024 annual report [3]. - The company has been expanding its production capacity overseas, particularly in Thailand, where it has established production lines for 3D printing materials, plastic dining utensils, and plant fiber products [3]. Group 4: Stock Performance - On September 18, the company's stock fell by 3.16%, with a trading volume of 83.15 million yuan and a turnover rate of 2.94%, resulting in a total market capitalization of 3.943 billion yuan [1]. - The average trading cost of the stock is 20.86 yuan, with the current price approaching a support level of 19.79 yuan [6].
泰恩康跌2.13%,成交额1.73亿元,主力资金净流出2034.24万元
Xin Lang Cai Jing· 2025-09-18 06:28
Group 1 - The core viewpoint of the news is that 泰恩康's stock has experienced fluctuations, with a notable decline of 2.13% on September 18, 2023, and a significant increase of 145.49% year-to-date [1] - As of September 18, 2023, 泰恩康's stock price is 36.31 CNY per share, with a total market capitalization of 15.45 billion CNY [1] - The company has seen a net outflow of main funds amounting to 20.34 million CNY, with large orders showing a buy of 41.42 million CNY and a sell of 44.88 million CNY [1] Group 2 - For the first half of 2023, 泰恩康 reported a revenue of 34.7 million CNY, a year-on-year decrease of 12.23%, and a net profit attributable to shareholders of 37.08 million CNY, down 56.75% year-on-year [2] - The company has distributed a total of 460 million CNY in dividends since its A-share listing, with 377 million CNY distributed over the past three years [3] Group 3 - 泰恩康's main business segments include pharmaceutical agency (65.16%), pharmaceutical manufacturing (31.70%), and pharmaceutical technology services and technology transfer (2.97%) [1] - The company is categorized under the pharmaceutical and biological industry, specifically in chemical pharmaceuticals and chemical preparations [1]